News Results
There are 987,575 News Results
Feb 20, 2025
MANASSAS, Va., Feb. 20, 2025 /PRNewswire/ --
Feb 20, 2025
As healthcare organizations grapple with financial pressures, many are looking to IT service commercialization as a strategy to stabilize their bottom line. New research insights from Info-Tech Research Group outline...
Feb 20, 2025
Create Immersive 4K Experiences: Colossal Touch Display Transforms Spaces into Dynamic Hubs of Interaction
Feb 21, 2025
GREEN COVE SPRINGS, Fla., Feb. 21, 2025 /PRNewswire/ -- Lennar, one of the nation's leading homebuilders, today announced the highly anticipated opening of the Amenity Center & Clubhouse, built exclusively...
Feb 22, 2025
Four decades after they were cruelly forced apart, US-raised Adamary Garcia and her birth mother fell into each other's arms Saturday at the airport in Santiago, Chile. Without speaking, they...
Feb 22, 2025
Unleash the Rhythm of Greatness: Empowering Musicians Everywhere
Feb 24, 2025
German conservative Friedrich Merz had just won the election when he dropped a bombshell: with Trump casting doubt on future defence ties, he said, Europe may have to look after...
Feb 25, 2025
ROLLING MEADOWS, Ill., Feb. 25, 2025 /PRNewswire/ -- As companies navigate an increasingly turbulent external environment, communications and HR leaders have identified 'change fatigue' as one of the top five...
Feb 25, 2025
SAN FRANCISCO and TROY, Mich., Feb. 25, 2025 /PRNewswire/ --
Feb 26, 2025
Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02
ADCE-T02 is a potential first-in-class Topoisomerase I inhibitor-based antibody-drug conjugate (ADC) targeting tissue factor, a validated ADC target overexpressed in multiple solid tumors
